RDD Pharma Appoints John Temperato as Chief Executive Officer

NEW YORK, March 18, 2019 -- (Healthcare Sales & Marketing Network) -- RDD Pharma, Inc., a specialty pharmaceutical company focused on innovative therapies for anorectal diseases and gastrointestinal disorders, today announced the appointment of industry v... Biopharmaceuticals, Gastroenterology, Personnel RDD Pharma, anal fissure, fecal incontinence, colitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news